欧洲抗风湿病联盟/欧洲血管炎研究组血管炎管理建议。
European League Against Rheumatism/European Vasculitis Study Group recommendations for the management of vasculitis.
机构信息
Center for Vasculitis Care and Research, Cleveland Clinic, Cleveland, Ohio 44195, USA.
出版信息
Curr Opin Rheumatol. 2010 Jan;22(1):49-53. doi: 10.1097/BOR.0b013e328332c9d1.
PURPOSE OF REVIEW
To discuss the European League Against Rheumatism recommendations in the management of primary systemic vasculitis.
RECENT FINDINGS
Important developments in the classification and treatment of systemic vasculitis have led the European League Against Rheumatism to publish recommendations in the diagnosis, treatment and monitoring of the small, medium and large-vessel vasculitides. These recommendations resulted from a combination of evidence from systematic analysis of selected studies and the experience of experts in vasculitis when data were not available.
SUMMARY
The purpose of formulating clinical recommendations is to improve quality of care and guide the clinician inexperienced with vasculitis. Nevertheless, patients with vasculitis should be managed by a vasculitis expert whenever possible. As our understanding of this rare and complex group of diseases advances, novel therapeutic options are being developed.
目的综述
讨论欧洲抗风湿病联盟在原发性系统性血管炎治疗管理中的建议。
最近的发现
系统性血管炎的分类和治疗方面的重要进展促使欧洲抗风湿病联盟在小、中、大血管血管炎的诊断、治疗和监测方面发布了建议。这些建议是基于对选定研究进行系统分析的证据以及血管炎专家在缺乏数据时的经验的综合。
总结
制定临床建议的目的是提高护理质量并指导临床医生治疗血管炎。然而，只要有可能，血管炎患者都应由血管炎专家进行管理。随着我们对这一罕见且复杂疾病群体的认识不断深入，新的治疗选择正在不断发展。
Zotero 插件